Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene

Clin Endocrinol (Oxf). 2012 Dec;77(6):934-6. doi: 10.1111/j.1365-2265.2012.04412.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Multiple Endocrine Neoplasia Type 2a / diagnosis
  • Multiple Endocrine Neoplasia Type 2a / genetics*
  • Multiple Endocrine Neoplasia Type 2a / therapy*
  • Mutation
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-ret / genetics*

Substances

  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-ret
  • RET protein, human